Trial Details
COMPLETEDBasic Information
| Clinical ID | c2272 |
|---|---|
| Identifier | NCT03757065 |
| Trial Title | Cell Surface Marker Expression in Autoimmune Diseases |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Systemic Lupus Erythematosus|Sjogren's Syndrome|Multiple Sclerosis|Systemic Sclerosis|Crohn's Disease|Ulcerative Colitis|Inflammatory Myositis |
| Interventions | - |
Participant Information
| Sponsor | Alpine Immune Sciences, Inc. |
|---|---|
| City | British Columbia |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2019-06-12 |
|---|---|
| Primary Completion Date | 2019-10-25 |
| Completion Date | 2019-10-25 |